AXA CEO The Impact of Obesity on Health Insurers

Name: AXA CEO The Impact of Obesity on Health Insurers
Uploaded: 2026-03-20T12:08:32.061Z
Duration: 1 min 17 s
Channel: Smart Finance
Description: AXA CEO Thomas Buberl says we are at the beginning of a revolution in obesity treatment. He shares details on how drugs like Ozempic will positively impact health insurers. He speaks on 'The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded January 30 in New York.

Smart Finance

3 Video Views·Mar 20, 2026

AXA CEO Thomas Buberl says we are at the beginning of a revolution in obesity treatment. He shares details on how drugs like Ozempic will positively impact health insurers. He speaks on 'The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded January 30 in New York.